Abstract: Pathological regional adipose tissue accumulation associated with HIV-associated dysmorphic/dysmetabolic syndrome (HADDS) which may occur with or without subcutaneous adipose tissue lipodystrophy (and which is also described as HIV-associated adipose redistribution syndrome or HARS and other specific medical terms), is treated by administering an effective amount of human growth hormone or other substance which binds to and initiates signalling of the hGH receptor. Alternatively, a substance which stimulates production of endogenous hGH, such as human growth hormone releasing hormone, may be administered. HADDS and related syndromes include abnormal adipose tissue accumulation in the visceral, submandibular, supraclavicular, pectoral, mammary and/or dorsocervical (buffalo hump) area, and/or with subcutaneous lipomas, with or without associated metabolic or other physiologic abnormalities.

Abstract: An automatic mechanism and method for moving a deadbolt between a retracted deadbolt position and an extended deadbolt position. A trigger is operatively coupled to the deadbolt and to the auxiliary latch. The trigger is configured to cause a first movement of the deadbolt from the retracted deadbolt position to the extended deadbolt position when the trigger moves from a first trigger position to a second trigger position, and to require movement of the auxiliary latch a predetermined distance from a retracted auxiliary-latch position toward an extended auxiliary-latch position before the trigger is able to cause a second movement of the deadbolt. The method includes as a step preventing the deadbolt from being released from the retracted deadbolt position until the auxiliary latch has moved a predetermined distance from the retracted auxiliary-latch position toward the extended auxiliary-latch position.

Abstract: A wall hanging assembly including a wall décor item having a generally horizontally oriented receiving surface and a wall mounting rail. The wall mounting rail having an elongate base portion with a back surface adapted to mount adjacent to a wall and a front surface. The wall mounting rail further having a level receptacle on the front surface and a level carried by the receptacle. The wall mounting rail includes a generally horizontally oriented support lip extending along at least part of the wall mounting rail and arranged to bear against the receiving surface of the wall décor item.

Abstract: Pathological regional adipose tissue accumulation associated with HIV-associated dysmorphic/dysmetabolic syndrome (HADDS) which may occur with or without subcutaneous adipose tissue lipodystrophy (and which is also described as HIV-associated adipose redistribution syndrome or HARS and other specific medical terms), is treated by administering an effective amount of human growth hormone or other substance which binds to and initiates signalling of the hGH receptor. Alternatively, a substance which stimulates production of endogenous hGH, such as human growth hormone releasing hormone, may be administered. HADDS and related syndromes include abnormal adipose tissue accumulation in the visceral, submandibular, supraclavicular, pectoral, mammary and/or dorsocervical (buffalo hump) area, and/or with subcutaneous lipomas, with or without associated metabolic or other physiologic abnormalities.

Abstract: A catheter having an elongated shaft and a balloon on a distal shaft section, the elongated shaft comprising an outer tubular member, and an inner tubular member which has a bonded portion along which an outer surface of the inner tubular member is bonded to an inner surface of the outer tubular member. The inner tubular member has a proximal portion proximal to the bonded portion, and a distal portion distal to the bonded portion with higher axial compression stiffness and column strength than the proximal portion thereof. The catheter has improved traceability, axial collapse resistance, pushability, and crossability, for improved ability to position the balloon at a desired location in a patient's body lumen.

Abstract: Pathological regional adipose tissue accumulation associated with HIV-associated dysmorphic/dysmetabolic syndrome (HADDS) which may occur with or without subcutaneous adipose tissue lipodystrophy (and which is also described as HIV-associated adipose redistribution syndrome or HARS and other specific medical terms), is treated by administering an effective amount of human growth hormone or other substance which binds to and initiates signalling of the hGH receptor. Alternatively, a substance which stimulates production of endogenous hGH, such as human growth hormone releasing hormone, may be administered. HADDS and related syndromes include abnormal adipose tissue accumulation in the visceral, submandibular, supraclavicular, pectoral, mammary and/or dorsocervical (buffalo hump) area, and/or with subcutaneous lipomas, with or without associated metabolic or other physiologic abnormalities.